Twins Lose Ober to Elbow Inflammation, Turn to Paredes Debut
By Erik Schwartz ·
Minnesota's rotation takes a hit as Bailey Ober heads to the injured list, forcing the organization to accelerate a prospect's timetable and reshape bullpen leverage.
The Twins placed right-hander Bailey Ober on the 15-day injured list Tuesday with elbow inflammation, per The Athletic. In the same move, they selected the contract of Mike Paredes from Triple-A, marking the infielder's major league debut. Travis Adams was recalled from the minor league affiliate to fill rotation depth.
Ober's absence creates an immediate gap in Minnesota's starting rotation. The 27-year-old right-hander has been a reliable mid-rotation piece, and elbow inflammation—even characterized as mild—carries inherent risk for a pitcher. The 15-day window suggests the Twins believe the issue is manageable, but the caution itself signals they're not betting on a quick return. Any pitcher placed for inflammation rather than a clean injury (strain, fracture) faces uncertainty about workload ramping when he does return; the inflammation could recur under stress, or it might resolve cleanly. That ambiguity matters for Minnesota's depth planning over the next month.
Paredes' promotion reflects organizational confidence in his readiness, but his arrival is a substitution play, not an upgrade. The Twins are moving a prospect into the active roster earlier than originally planned—a schedule compression forced by Ober's setback. Paredes will need regular at-bats to stay sharp; sporadic pinch-hit duty won't develop him. Minnesota's infield depth will tighten, and the team will lean more heavily on its bench flexibility. This is the kind of cascading roster churn that doesn't appear in headlines but compounds innings-count pressure across multiple position players and relief arms over a two-week stretch.
From a betting lens, Twins run production faces headwind. Ober has logged roughly 95 innings per season with a 4.2 ERA; his removal pushes a lower-tier starter into the rotation for at least one or two turns. Adams, the recalled arm, carries none of Ober's track record. Minnesota's bullpen will also see elevated usage if the replacement starter doesn't match Ober's innings per outing. Shorter starts + more relief appearances = higher variance in game totals and heightened churn risk for team run totals. Against opponents that exploit fastball-heavy bullpen arms, the Twins' margin for error shrinks.
Take unders on Minnesota team totals for the next 10-14 days, particularly in games where Adams starts or Ober's absence forces unconventional bullpen construction. The edge is not that the Twins will collapse—they won't—but that the market hasn't yet fully priced the inefficiency cost of mid-rotation loss plus prospect integration. That inefficiency fades once the rotation stabilizes and Paredes gets regular reps, so the window is narrow. Early numbers before line adjustments capture the edge; avoid chasing after sharp money has already moved totals.